L&C Bio Co., Ltd
290650.KQFinancial Statements
Income Statement (Annual)
Amounts in millions
2024
12/31/2024
Revenue
54
Cost of Revenue
27
Gross Profit
27
Gross Margin
49.6%
Operating Income
2
Operating Margin
3.5%
Net Income
106
Net Margin
195.7%
EPS (Basic)
$5.00
EPS (Diluted)
$4.00
EBITDA
111
EBITDA Margin
205.0%
2023
12/31/2023
Revenue
52
Cost of Revenue
24
Gross Profit
25
Gross Margin
49.2%
Operating Income
5
Operating Margin
10.2%
Net Income
36
Net Margin
70.2%
EPS (Basic)
$2.00
EPS (Diluted)
$2.00
EBITDA
11
EBITDA Margin
21.5%
2022
12/31/2022
Revenue
39
Cost of Revenue
19
Gross Profit
20
Gross Margin
51.3%
Operating Income
7
Operating Margin
18.0%
Net Income
3
Net Margin
8.6%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
11
EBITDA Margin
27.1%
2021
12/31/2021
Revenue
34
Cost of Revenue
13
Gross Profit
21
Gross Margin
62.3%
Operating Income
10
Operating Margin
28.8%
Net Income
10
Net Margin
30.2%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
13
EBITDA Margin
36.6%
2020
12/31/2020
Revenue
25
Cost of Revenue
10
Gross Profit
15
Gross Margin
59.3%
Operating Income
5
Operating Margin
22.2%
Net Income
8
Net Margin
32.8%
EPS (Basic)
$0.00
EPS (Diluted)
$0.00
EBITDA
7
EBITDA Margin
30.0%